Tumor markers at the time of recurrence in patients with germ cell tumors

Cancer

Volumn 88, Issue 1, 2000, Pages 162-168

  Trigo, José M ^a,e   Tabernero, José M ^b   Paz Ares, Luis ^a   Garcia Llano, José L ^d   Mora, José ^c   Lianes, Pilar ^a   Esteban, Emilio ^d   Salazar, Ramón ^b   López López, Juan J ^b   Cortés Funes, Hernán ^a  

^a Serv Oncologia Medica Hosp U   (Spain)

^b Serv Oncologia Medica Clin H   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d Serv Oncologia Medica Hosp C   (Spain)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

fetoprotein; Follow up; Germ cell tumor; Human chorionic gonadotropin; Lactate dehydrogenase; Recurrence; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; CHORIONIC GONADOTROPIN; CISPLATIN; LACTATE DEHYDROGENASE; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CONTROLLED STUDY; FOLLOW UP; GERM CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEMINOMA; SPAIN;

ADOLESCENT; ADULT; AGED; ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; GERMINOMA; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MEDICAL RECORDS; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SPAIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0033961811     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000101)88:1<162::AID-CNCR22>3.0.CO;2-V     Document Type: Article

References (27)

1. Einhorn LH. Karnofsky Memorial Lecture. Treatment of testicular cancer: a new and improved model. J Clin Oncol 1990;8:1777-81.
2. Kurman RJ, Scardino PT, McIntire KR, Waldmann TA, Javadpour N. Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using an indirect immunoperoxidase technique. A new approach to classification utilizing tumor markers. Cancer 1977;40:2136-51.
3. Bosl GJ, Geller NL, Cirrincione C, Nisselbaum J, Vugrin D, Whitmore WF Jr., et al. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience. Am J Med 1983;75:29-35.
4. Price A, Nicholls J, Norman A, Dearnaley D, Horwich A. Tumour markers at relapse in patients with non-seminomatous germ cell tumors. Ann Oncol 1994;5(Suppl 8):63.
5. Lange PH, McIntire KR, Waldmann TA, Hakala TR, Fraley EE. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer. N Engl J Med 1976;295: 1237-40.
6. Bates SE, Longo DL. Use of serum tumor markers in cancer diagnosis and management. Semin Oncol 1987;14:102-38.
7. Ball D, Barret A, Peckham MJ. The management of metastatic seminoma testis. Cancer 1982;50:2289-94.
8. Weissbach L, Bussar-Maatz R. HCG-positive seminoma. Eur Urol 1993;23(Suppl 2):29-32.
9. Mauch P, Weichselbaum R, Botnick L. The significance of positive chorionic gonadotropins in apparently pure seminoma of the testis. Int J Radiat Oncol Biol Phys 1979;5:887-9.
10. Fossa A, Fossa SD. Serum lactate dehydrogenase and human choriogonadotrophin in seminoma. Br J Urol 1989;63: 408-15.
11. Waldmann TA, McIntire KR. The use of radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancy. Cancer 1974;34(Suppl 4):1510-5.
12. Moore MR, Garrett PR Jr., Walton KN, Waldmann TA, McIntire RK, Vogel CL. Evaluation of human chorionic gonadotropin and alpha fetoprotein in benign and malignant testicular disorders. Surg Gynecol Obstet 1978;147:167-74.
13. Klepp O, Flodgren P, Maartman-Moe H, Lindholm CE, Unsgaard B, Teigum H, et al. Early clinical stages (CS1, CS1 Mk+ and CS2) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA). Ann Oncol 1990;1:281-8.
14. Raghavan D, Sullivan AL, Peckham MJ, Neville AM. Elevated serum alphafetoprotein and seminoma: clinical evidence for histologic continuum? Cancer 1982;50:982-9.
15. The International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997;15:594-603.
16. Rorth M, Cullen MH, Horwich A, Roth BJ. Management of patients with non-seminomatous germ cell tumours stage I. Prog Clin Biol Res 1990;357:295-303.
17. Cullen M. Management of stage I non-seminoma: surveillance and chemotherapy. In: Horwich A, editor. Testicular cancer: investigation and management. London: Chapman and Hall Medical, 1991:149-68.
18. Bartlett NL, Freiha FS, Torti FM. Serum markers in germ cell neoplasms. Hematol Oncol Clin North Am 1991;5:1245-60.
19. Toner GC, Panicek DM, Heelan RT, Geller NL, Lin SY, Bajorin D, et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 1990;8:1683-94.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
21. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A 1972;35:185-206.
22. Gerl A, Clemm C, Schmeller N, Hartenstein R, Lamerz R, Wilmanns W. Prognosis after salvage treatment for unselected male patients with germ cell tumours. Br J Cancer 1995;72:1026-32.
23. Horwich A, A'Hearn R, Gildersleve J, Dearnaley DP. Prognostic factor analysis of conventional dose salvage therapy of patients with metastatic nonseminomatous germ cell cancer. Proc Annu Meet Am Soc Clin Oncol 1993;12: 232.
24. Williams MP, Husband JE, Heron CW. Stage I nonseminomatous germ cell tumors of the testis: radiologic follow-up after orchidectomy. Radiology 1987;164:671-4.
25. Thompson PI, Nixon J, Harvey VJ. Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance. J Clin Oncol 1988;6:1597-603.
26. Seckl MJ, Rustin GJ, Bagshawe KD. Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours. Br J Cancer 1990;61:916-8.
27. Mirimanoff RO, Shipley WU, Dosoretz DE, Meyer JE. Pure seminoma of the testis: the results of radiation therapy in patients with elevated human chorionic gonadotropin titers. J Urol 1985;134:1124-6.